China Universal Asset Management Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
PBBUPS
AS
China Universal Asset Management Company's NBIX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Neurocrine Biosciences (NBIX) stake by 10% in Q2 2026, selling an estimated $268K and leaving 16,003 shares worth $2.7M. The position accounts for 0.16% of the portfolio, ranked #101.
China Universal Asset Management Company first reported a position in NBIX in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.93M in Q4 2024. 262 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.
- China Universal Asset Management Company held 16,003 shares of Neurocrine Biosciences worth $2.7M as of Q2 2026.
- China Universal Asset Management Company sold 1,807 Neurocrine Biosciences shares in Q2 2026, an estimated $268K.
- Neurocrine Biosciences made up 0.16% of China Universal Asset Management Company's portfolio in Q2 2026, its #101 holding.
- China Universal Asset Management Company first reported a position in Neurocrine Biosciences in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Neurocrine Biosciences position peaked at $2.93M in Q4 2024.
- 262 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.